The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.

Studies designed, executed, and funded by an Alkermes company.

Filter Publications
Therapeutic Area:
Publication Type:
Showing 3 of 103 results
Sort by date: Descending
Sep 2007
Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment
The Journal of Clinical Pharmacology
AUTHOR(S)

O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR

View on PubMed
Clinical
Alcohol Use Disorder
Mar 2006
Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone
Alcoholism: Clinical and Experimental Research
AUTHOR(S)

Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC

View on PubMed
Clinical
Alcohol Use Disorder
Opioid Use Disorder
Apr 2005
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial
JAMA
AUTHOR(S)

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW, et al.

View on PubMed
Clinical
Alcohol Use Disorder